The 2004 WHO classification of bladder tumors: A summary and commentary

被引:198
作者
Montironi, R
Lopez-Beltran, A
机构
[1] Polytech Univ Marche Reg Ancona, Inst Pathol Anat & Histopathol, I-60020 Ancona, Italy
[2] Univ Cordoba, Reina Sofia Hosp, Dept Pathol, Cordoba, Spain
[3] Univ Cordoba, Sch Med, Cordoba, Spain
关键词
bladder cancer; pathology; genetics;
D O I
10.1177/106689690501300203
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The key points of the latest World Health Organization (WHO) classification of noninvasive urothelial tumors are the following: the description of the categories has been expanded to improve their recognition; a tumor with particularly good prognosis (papillary urothelial neoplasm of low malignant potential) no longer carries the label of 'cancer'; it avoids the use of ambiguous grading such as grade 1/2 or 2/3 (as done in the 1973 WHO classification); the group of noninvasive high-grade carcinoma is large enough to virtually contain all those tumors having biological properties similar to those seen in invasive urothelial carcinoma, and a similarly high level of genetic instability. This scheme is meant to replace the 1973 WHO classification, but the use of both the 1973 and the latest WHO classifications is recommended until the latter is sufficiently validated.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 38 条
[1]   Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors [J].
Alsheikh, A ;
Mohamedali, Z ;
Jones, E ;
Masterson, J ;
Gilks, CB .
MODERN PATHOLOGY, 2001, 14 (04) :267-272
[2]   Urothelial papillary (exophytic) neoplasms [J].
Bostwick, DG ;
Mikuz, G .
VIRCHOWS ARCHIV, 2002, 441 (02) :109-116
[3]   Diagnosis and grading of bladder cancer and associated lesions [J].
Bostwick, DG ;
Ramnani, D ;
Cheng, L .
UROLOGIC CLINICS OF NORTH AMERICA, 1999, 26 (03) :493-+
[4]   The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems [J].
Busch, C ;
Algaba, F .
VIRCHOWS ARCHIV, 2002, 441 (02) :105-108
[5]   Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder [J].
Cheng, L ;
MacLennan, GT ;
Zhang, SB ;
Wang, MS ;
Pan, CX ;
Koch, MO .
CANCER, 2004, 101 (01) :183-188
[6]  
Cheng L, 1999, CANCER, V86, P2102, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2102::AID-CNCR31>3.0.CO
[7]  
2-U
[8]   Natural history of urothelial dysplasia of the bladder [J].
Cheng, L ;
Cheville, JC ;
Neumann, RM ;
Bostwick, DG .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (04) :443-447
[9]   Genetic and molecular markers of urothelial premalignancy and malignancy [J].
Cordon-Cardo, C ;
Cote, RJ ;
Sauter, G .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2000, 34 :82-93
[10]   Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia [J].
Desai, S ;
Lim, SD ;
Jimenez, RE ;
Chun, T ;
Keane, TE ;
McKenney, JK ;
Zavala-Pompa, A ;
Cohen, C ;
Young, RH ;
Amin, MB .
MODERN PATHOLOGY, 2000, 13 (12) :1315-1323